Pharmaceutical Executive October 11, 2024
Ira Studin, PhD

A value deficit and potential consumer value proposition.

At some point, something new in a particular market becomes a development and, occasionally, if the development has sufficient traction, it can reshape a market. This discussion suggests Amazon’s presence in the pharma market could potentially fit that picture for the part of the market that falls below specialty products and orphan conditions.

Amazon’s healthcare business focuses on what might be called the transactional dimension of the healthcare system. It targets the time, scheduling, and financial burden patients experience. Its underlying assumption is that this burden is increasing and by leveraging its core competency in IT and operations, it can make a business by leaning into logistics to produce superior customer value.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Overprescribing and Polypharmacy: Arine CEO Talks The Hidden Dangers of Amazon’s Same-Day Prescription Delivery
Good Neighbor Pharmacy’s Tech Rx: Helping Independents Thrive in a Changing Market
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care

Share This Article